MutualFundWire.com
   The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication |
Thursday, February 8, 2001 In Demand Investors clamoring for more ETFs got what they wanted, as Barclays Global International introduced a new iShare, under the ticker symbol IBB, that tracks the Nasdaq Biotechnology Index. "An exchange traded fund that tracks the biotech sector was one of the most requested from our customers," said Lee Kranefuss, chief executive officer of BGI's Individual Investor Group in a statement. The companies followed by the index develop new treatments and cures from biomedical research. Printed from: MFWire.com/story.asp?s=26414 Copyright 2001, InvestmentWires, Inc. All Rights Reserved |